PROMACTA Trademark

Trademark Overview


On Tuesday, June 25, 2013, a trademark application was filed for PROMACTA with the United States Patent and Trademark Office. The USPTO has given the PROMACTA trademark a serial number of 85969206. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 18, 2024. This trademark is owned by GlaxoSmithKline LLC. The PROMACTA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

providing healthcare information to patients and healthcare professionals via the internet
promacta

General Information


Serial Number85969206
Word MarkPROMACTA
Filing DateTuesday, June 25, 2013
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 18, 2024
Registration Number4475188
Registration DateTuesday, January 28, 2014
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 12, 2013

Trademark Statements


Description of MarkThe mark consists of the term "PROMACTA" in purple with the letter "o" in red. To the left of the wording are six stylized blood cells, four of which are purple and two of which are red.
Indication of Colors claimedThe color(s) purple and red is/are claimed as a feature of the mark.
Goods and Servicesproviding healthcare information to patients and healthcare professionals via the internet

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 8, 2013
Primary Code044
First Use Anywhere DateThursday, June 7, 2012
First Use In Commerce DateThursday, June 7, 2012

Trademark Owner History


Party NameNOVARTIS PHARMA AG
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
Address4056 BASEL 4056
CH

Party NameGlaxoSmithKline LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Party NameGlaxoSmithKline LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Party NameGlaxoSmithKline LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Trademark Events


Event DateEvent Description
Friday, June 28, 2013NEW APPLICATION ENTERED
Monday, July 8, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 9, 2013NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 3, 2013ASSIGNED TO EXAMINER
Friday, October 4, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2013PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 2, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 28, 2014REGISTERED-PRINCIPAL REGISTER
Wednesday, February 17, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 2, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 28, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 8, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, March 4, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 4, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 4, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, January 28, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, December 13, 2023TEAS SECTION 8 & 9 RECEIVED
Thursday, April 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 18, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 18, 2024REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 18, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED